Adoptive cellular therapy improves Parkinson’s symptoms in mouse-model study
UF neuroscientists provide preclinical evidence for adoptive cellular therapy as a potential immunotherapy treatment to improve symptoms in genetic form of Parkinson’s.
Posts tagged as
David Vaillancourt
Eight UF research teams awarded MBI grant funding
$744K in grants will support UF research projects and equipment.
HIV drug shows potential to combat form of dystonia in preclinical study
In mouse-model research, HIV medication restored brain abnormalities in DYT1.
AI tool to be tested for improved Parkinson’s diagnosis
Researchers launch study to aid in quick and accurate early Parkinson’s diagnosis versus two related but distinct disorders.
